Pfizer 2016 Annual Review: Accelerating Patient Impact

Primary tabs

Pfizer 2016 Annual Review: Accelerating Patient Impact

Pfizer’s 2016 integrated annual review provides an in-depth report of the company’s financial, social and environmental performance throughout 2016. This year’s online report underscores how Pfizer worked to accelerate patient impact through partnerships, clinical advancements and innovative solutions that addressed the individual needs of patients worldwide.

View the full report at www.pfizer.com/annual and continue to check back on this page for highlights from the 2016 Annual Review.

Content from this campaign

Bringing Resources to Bear to Improve Global Health
At Pfizer, we believe our business and societal missions are the same: ensuring all individuals everywhere have access to quality medicines, vaccines and health care, and the opportunity to lead healthy lives. Every day, we strive to use our full resources – our people, products and funding – to find new ways to positively impact the health of people around the world and across their lifespan...
Apr 28, 2017 10:00 AM ET
Pfizer’s Progress on 2020 Waste Reduction Goals
In alignment with the global sustainable development goals, Pfizer has committed to reduce its total hazardous and non-hazardous waste disposal by 15 percent by 2020.  Learn more about Pfizer’s progress in waste reduction: ...
Apr 19, 2017 10:00 AM ET
Using the Power of Technology & Innovative Science to Advance Patient Care
There have been great strides made recently in treating the most difficult and debilitating health conditions people face. Yet, there is still much work to be done if we are going to find truly effective therapies for these conditions. At Pfizer, we work to make our drug development process more efficient by collaborating with unique partners and exploring new pathways that harness technology...
Apr 13, 2017 10:00 AM ET
Providing Patients with Global Health Resources
Pfizer believes that all individuals deserve access to quality health care and the opportunity to lead healthy lives. We combine creative commercial strategies with philanthropic approaches to create a sustainable and meaningful impact on global health. In 2016, we made significant strides in advancing this goal, including: Delivering the 250 millionth dose of the company’s...
Apr 4, 2017 10:00 AM ET
Creating a Blueprint for Eliminating Trachoma
After more than six decades of fighting the spread of trachoma in Morocco, on November 14, 2016, the World Health Organization (WHO) acknowledged that the Moroccan government eliminated the world’s leading infectious cause of blindness as a public health problem. Pfizer's antibiotic donation, in partnership with the International Trachoma Initiative (ITI), as well as the implementation...
Mar 27, 2017 11:00 AM ET

Pages